These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30885952)

  • 41. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
    Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
    BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of retirement on nonadherence to medication for hypertension and diabetes.
    Kivimäki M; Batty GD; Hamer M; Nabi H; Korhonen M; Huupponen R; Pentti J; Oksanen T; Kawachi I; Virtanen M; Westerlund H; Vahtera J
    CMAJ; 2013 Nov; 185(17):E784-90. PubMed ID: 24082018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice.
    van Bruggen R; Gorter K; Stolk RP; Zuithoff P; Klungel OH; Rutten GE
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):983-91. PubMed ID: 19623570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis.
    Abegaz TM; Shehab A; Gebreyohannes EA; Bhagavathula AS; Elnour AA
    Medicine (Baltimore); 2017 Jan; 96(4):e5641. PubMed ID: 28121920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetes mellitus in the United Kingdom.
    Tunceli K; Iglay K; Zhao C; Brodovicz KG; Radican L
    Diabetes Res Clin Pract; 2015 Sep; 109(3):e27-31. PubMed ID: 26233933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the Republic of Korea.
    An SY; Kim HJ; Chun KH; Kim TH; Jeon JY; Kim DJ; Han SJ; Kim YS; Woo JT; Ahn KJ; Park Y; Nam M; Baik SH; Lee KW
    Clin Ther; 2014 Feb; 36(2):245-54. PubMed ID: 24480636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adherence behavior assessment of oral antidiabetic medication use: a study of patient decisions in long-term disease management in primary health care centers in Surabaya.
    Aditama L; Athiyah U; Utami W; Rahem A
    J Basic Clin Physiol Pharmacol; 2020 Jan; 30(6):. PubMed ID: 31953995
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of incident depression on medication adherence in patients with type 2 diabetes.
    Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
    Diabetes Metab; 2017 Dec; 43(6):521-528. PubMed ID: 28822618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Highly Tailored Text and Voice Messaging Intervention to Improve Medication Adherence in Patients With Either or Both Hypertension and Type 2 Diabetes in a UK Primary Care Setting: Feasibility Randomized Controlled Trial of Clinical Effectiveness.
    Kassavou A; Mirzaei V; Brimicombe J; Edwards S; Massou E; Prevost AT; Griffin S; Sutton S
    J Med Internet Res; 2020 May; 22(5):e16629. PubMed ID: 32427113
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adherence to Newly Prescribed Diabetes Medications Among Insured Latino and White Patients With Diabetes.
    Fernández A; Quan J; Moffet H; Parker MM; Schillinger D; Karter AJ
    JAMA Intern Med; 2017 Mar; 177(3):371-379. PubMed ID: 28114642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes.
    Lau DT; Nau DP
    Diabetes Care; 2004 Sep; 27(9):2149-53. PubMed ID: 15333476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?
    Long JA; Wang A; Medvedeva EL; Eisen SV; Gordon AJ; Kreyenbuhl J; Marcus SC
    Diabetes Care; 2014 Aug; 37(8):2261-7. PubMed ID: 24879839
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes management in an Australian primary care population.
    Krass I; Hebing R; Mitchell B; Hughes J; Peterson G; Song YJ; Stewart K; Armour CL
    J Clin Pharm Ther; 2011 Dec; 36(6):664-72. PubMed ID: 21355875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Costs and beliefs: understanding individual- and neighborhood-level correlates of medication nonadherence among Mexican Americans with type 2 diabetes.
    Billimek J; August KJ
    Health Psychol; 2014 Dec; 33(12):1602-5. PubMed ID: 24295022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preferential adherence to immunosuppressive over nonimmunosuppressive medications in kidney transplant recipients.
    Terebelo S; Markell M
    Transplant Proc; 2010 Nov; 42(9):3578-85. PubMed ID: 21094819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
    Oladapo AO; Barner JC; Rascati KL; Strassels SA
    Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medication adherence among patients with apparent treatment-resistant hypertension: systematic review and meta-analysis.
    Durand H; Hayes P; Morrissey EC; Newell J; Casey M; Murphy AW; Molloy GJ
    J Hypertens; 2017 Dec; 35(12):2346-2357. PubMed ID: 28777133
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
    McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
    J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.